Rethinking Alzheimer’s: Novel miRNAs Illuminate a Disease Beyond the Brain
Open accessPreprint — published as 10.1038/s41380-026-03487-6 · Paper page
Abstract
Alzheimer’s disease (AD) poses major health, social and economic challenges to the modern world. Despite the advances in understanding AD, our knowledge about its pathogenesis remains incomplete. Recent data suggest that circulating microRNAs (miRNAs) undergo complex changes in AD. Since these changes are yet to be comprehensively characterized, we investigated miRNAs in the context of AD using two meta-analytical approaches. We reproducibly identified 2895 miRNAs in a cohort of 4186 individuals from 22 studies. Here we show that 194 miRNAs exhibited widespread changes in AD, including some novel miRNAs not yet linked to AD. These novel AD miRNAs broaden the landscape of research on the role of miRNAs in AD. Targets of these miRNAs further uncovered many biological pathways that, to date, remain poorly understood in AD with several “AD miRNAs” never described in the brain. “AD miRNAs” described outside the brain significantly influenced interleukin signaling, Toll receptor signaling, p38 MAPK pathway and insulin/IGF pathway. Our results reveal a greater complexity of biological pathways involved in AD than previously thought and raise the question of whether AD is indeed a brain-specific and not a systemic disorder. These findings advance current understanding of AD pathogenesis and lay the ground for the development of next-generation AD biomarkers and design of miRNA-engaged therapies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · see citing works
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · see citing works
ShinyGO: a graphical gene-set enrichment tool for animals and plants
Ge, S. X., Jung, D., & Yao, R. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz931 · Cited by 5,270 · see citing works
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y. C., Huang, K., Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,754 · see citing works
Ambros, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00616-x · Cited by 1,704 · see citing works
Adipose-derived circulating miRNAs regulate gene expression in other tissues
Thomou, T., Mori, M. A., Dreyfuss, J. M., Konishi, M., Sakaguchi, M., Wolfrum, C., Rao, T. N., Winnay, J. N., Garcia-Martin, R., Grinspoon, S. K., et al. (2017) · Nature · doi:10.1038/nature21365 · Cited by 1,539 · see citing works
Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001450 · Cited by 1,367 · see citing works
Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2021.07.010 · Cited by 1,313 · see citing works
Gibbings, D., Ciaudo, C., Erhardt, M., & Voinnet, O. (2009) · Nature Cell Biology · doi:10.1038/ncb1929 · Cited by 990 · see citing works
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · see citing works
Wang, W., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., & Nelson, P. T. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5065-07.2008 · Cited by 827 · see citing works
MicroRNA sequence codes for small extracellular vesicle release and cellular retention
García-Martín, R., Wang, G., Brandão, B. B., Zanotto, T. M., Shah, S., Patel, S. K., Schilling, B., & Kahn, C. R. (2021) · Nature · doi:10.1038/s41586-021-04234-3 · Cited by 739 · see citing works
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus
Lukiw, W. J. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3280148e8b · Cited by 662 · see citing works
A blood based 12-miRNA signature of Alzheimer disease patients
Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Mueller, S. C., Frese, K., Haas, J., Ruprecht, K., Paul, F., Stähler, C., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-7-r78 · Cited by 498 · see citing works
Song, S. J., Poliseno, L., Song, M. S., Ala, U., Webster, K. A., Ng, C., Beringer, G., Brikbak, N. J., Yuan, X., Cantley, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.026 · Cited by 491 · see citing works
Lugli, G., Cohen, A. M., Bennett, D. A., Shah, R. C., Fields, C. J., Hernandez, A. G., & Smalheiser, N. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139233 · Cited by 423 · see citing works
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease
Hur, J.-Y., Frost, G. R., Wu, X., Crump, C., Pan, S. J., Wong, E., Barros, M., Li, T., Nie, P., Zhai, Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2681-2 · Cited by 382 · see citing works
Hébert, S. S., Papadopoulou, A. S., Smith, P. Y., Galas, M., Planel, E., Silahtaroglu, A., Sergeant, N., Buée, L., & Strooper, B. D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq311 · Cited by 323 · see citing works
Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease
Geekiyanage, H., Jicha, G. A., Nelson, P. T., & Chan, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.026 · Cited by 292 · see citing works
Das, S., Abdel‐Mageed, A. B., Adamidi, C., Adelson, P. D., Akat, K. M., Alsop, E. B., Ansel, K. M., Arango, J. I., D, N. A. M., Kilinc, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.023 · Cited by 223 · see citing works
Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
Dong, H., Li, J., Huang, L., Chen, X., Li, D., Wang, T., Hu, C., Xu, J. L., Zhang, C., Zen, K., et al. (2015) · Disease Markers · doi:10.1155/2015/625659 · Cited by 214 · see citing works
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes
Perry, E. K., Blessed, G., Tomlinson, B. E., Perry, R. H., Crow, T. J., Cross, A. J., Dockray, G. J., Dimaline, R., & Arregui, A. (1981) · Neurobiology of Aging · doi:10.1016/0197-4580(81)90032-4 · Cited by 212 · see citing works
MicroRNAs can regulate human APP levels
Patel, N., Hoang, D. M., Miller, N., Ansaloni, S., Huang, Q., Rogers, J. T., Lee, J. C., & Saunders, A. J. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-10 · Cited by 205 · see citing works
miRTargetLink 2.0—interactive miRNA target gene and target pathway networks
Kern, F., Aparicio-Puerta, E., Li, Y., Fehlmann, T., Kehl, T., Wagner, V., Ray, K., Ludwig, N., Lenhof, H.-P., Meese, E., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab297 · Cited by 203 · see citing works
Changes of p53 in the Brains of Patients with Alzheimer's Disease
Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6301 · Cited by 185 · see citing works
Do infections have a role in the pathogenesis of Alzheimer disease?
Itzhaki, R. F., Golde, T. E., Heneka, M. T., & Readhead, B. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0323-9 · Cited by 173 · see citing works
Chow, H.-M., Shi, M., Cheng, A., Gao, Y., Chen, G., Song, X., So, R. W. L., Zhang, J., & Herrup, K. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0505-1 · Cited by 171 · see citing works
Plasma microRNA biomarkers for detection of mild cognitive impairment
Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., & Umansky, S. R. (2012) · Aging · doi:10.18632/aging.100486 · Cited by 158 · see citing works
MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
Kumar, S., Vijayan, M., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx267 · Cited by 157 · see citing works
Changes in Blood Glucose and Insulin Secretion in Patients with Senile Dementia of Alzheimer Type
Bucht, G., Adolfsson, R., Lithner, F., & Winblad, B. G. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb03756.x · Cited by 140 · see citing works
Lanni, C., Masi, M., Racchi, M., & Govoni, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0760-2 · Cited by 130 · see citing works
Fujisawa, Y., Sasaki, K., & Akiyama, K. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90158-i · Cited by 113 · see citing works
Dong, Z., Gu, H., Guo, Q., Liang, S., Xue, J., Yao, F., Liu, X., Li, F., Liu, H., Sun, L., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02323-y · Cited by 103 · see citing works
Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
Young‐Pearse, T. L., Lee, H., Hsieh, Y., Chou, V., & Selkoe, D. J. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.03.005 · Cited by 99 · see citing works
Tsartsalis, S., Sleven, H., Fancy, N., Wessely, F., Smith, A. M., Willumsen, N., Cheung, T. K. D., Rokicki, M. J., Chau, V., Ifie, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46630-z · Cited by 95 · see citing works
Nie, C., Sun, Y., Zhen, H., Guo, M. L., Ye, J., Liu, Z., Yang, Y. X., & Zhang, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00438 · Cited by 89 · see citing works
Denk, J., Oberhauser, F., Kornhuber, J., Wiltfang, J., Fassbender, K. C., Schroeter, M. L., Volk, A. E., Diehl‐Schmid, J., Prudlo, J., Danek, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197329 · Cited by 87 · see citing works
Rishik, S., Hirsch, P., Grandke, F., Fehlmann, T., & Keller, A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1036 · Cited by 79 · see citing works
Machine Learning to Detect Alzheimer’s Disease from Circulating Non-Coding RNAs
Ludwig, N., Fehlmann, T., Kern, F., Gogol, M., Maetzler, W., Deutscher, S., Gurlit, S., Schulte, C., von Thaler, A., Deuschle, C., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.09.004 · Cited by 77 · see citing works
Plagman, A. K., Hoscheidt, S. M., McLimans, K. E., Klinedinst, B. S., Pappas, C. A., Anantharam, V., Kanthasamy, A. G., & Willette, A. A. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.002 · Cited by 70 · see citing works
Validating Alzheimer's disease micro RNAs using next‐generation sequencing
Keller, A., Backes, C., Haas, J., Leidinger, P., Maetzler, W., Deuschle, C., Berg, D., Ruschil, C., Galata, V., Ruprecht, K., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.12.012 · Cited by 67 · see citing works
Ageing, A. T. A. I. B. A. L. F. S. O., Wu, H. Z. Y., Thalamuthu, A., Cheng, L., Fowler, C. J., Masters, C. L., Sachdev, P. S., & Mather, K. A. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00627-0 · Cited by 66 · see citing works
Control of RNA silencing and localization by endolysosomes
Gibbings, D., & Voinnet, O. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.06.001 · Cited by 65 · see citing works
Shigemizu, D., Akiyama, S., Asanomi, Y., Boroevich, K. A., Sharma, A. K., Tsunoda, T., Matsukuma, K., Ichikawa, M., Sudo, H., Takizawa, S., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0324-7 · Cited by 60 · see citing works
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease
Visconte, C., Fenoglio, C., Serpente, M., Muti, P. C., Sacconi, A., Rigoni, M., Arighi, A., Borracci, V., Arcaro, M., Arosio, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914749 · Cited by 54 · see citing works
Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex
Mazurek, M. F., & Beal, F. M. (1991) · Neurology · doi:10.1212/wnl.41.5.716 · Cited by 53 · see citing works
Fitz, N. F., Wang, J., Kamboh, M. I., Koldamova, R., & Lefterov, I. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105481 · Cited by 49 · see citing works
Wolfrum, P., Fietz, A., Schnichels, S., & Hurst, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1029473 · Cited by 47 · see citing works
Pivotal role of RanBP9 in integrin‐dependent focal adhesion signaling and assembly
Woo, J. A., Roh, S., Lakshmana, M. K., & Kang, D. E. (2012) · The FASEB Journal · doi:10.1096/fj.11-194423 · Cited by 45 · see citing works
Analysis of Serum miRNAs in Alzheimer’s Disease
Liu, L., Dai, W.-Z., Zhu, X., & Ma, T. (2021) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175211021712 · Cited by 43 · see citing works
Toma, I. D., Sierra, C., & Dierssen, M. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009317 · Cited by 32 · see citing works
Xu, H., Liu, X., Li, W., Ye, X., Su, P., Meng, B., Shao, X., Tang, B., Yang, Q., & Mao, Z. (2021) · Aging Cell · doi:10.1111/acel.13434 · Cited by 26 · see citing works
Self-citationWang, L., Zhen, H., Sun, Y., Rong, S., Li, B., Song, Z., Liu, Z., Li, Z., Ding, J., Yang, H., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03012-0 · Cited by 25 · see citing works
Amanida: an R package for meta-analysis of metabolomics non-integral data
Llambrich, M., Correig, E., Gumà, J., Brezmes, J., & Cumeras, R. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab591 · Cited by 24 · see citing works
Lee, J. K., Raghavan, S., Christenson, L. R., Frank, R. D., Kantarci, K., Rocca, W. A., Vemuri, P., & Mielke, M. M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13890 · Cited by 21 · see citing works
Durairajan, S. S. K., Selvarasu, K., Singh, A. K., Patnaik, S., Iyaswamy, A., Jaiswal, Y., Williams, L. L., & Huang, J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1432002 · Cited by 18 · see citing works
Bassil, D. T., Zheng, B., Su, B., Kafetsouli, D., Udeh‐Momoh, C. T., Tzoulaki, I., Ahmadi‐Abhari, S., Muller, D. C., Ríboli, E., & Middleton, L. T. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.135 · Cited by 17 · see citing works
Wen, Q., Wittens, M. M. J., Engelborghs, S., van Herwijnen, M. H. M., Tsamou, M., Roggen, E., Smeets, H. J. M., Krauskopf, J., & Briedé, J. J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00740 · Cited by 14 · see citing works
Batabyal, R., Bansal, A., Cechinel, L. R., Authelet, K. J., Goldberg, M., Nadler, E. P., Keene, C. D., Jayadev, S., Domoto‐Reilly, K., Li, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814024 · Cited by 12 · see citing works
Biomarker profiling to determine clinical impact of microRNAs in cognitive disorders
Zhai, W., Zhao, M., Wei, C., Zhang, G., Qi, Y., Zhao, A., & Sun, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-58882-2 · Cited by 12 · see citing works
Blood levels of cytokines highlight the role of inflammation in Alzheimer's disease
Campanelli, L., Galeano, P., Prestia, F. A., Cuesta, C., Dalmasso, M. C., Flores-López, M., Gona, C., Irureta, N., Kairiyama, C., Lisso, J., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41725 · Cited by 12 · see citing works
Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment
Reiss, A. B., Housny, M., Gulkarov, S., Hossain, T., Locke, B., Srivastava, A., Pinkhasov, A., Gomolin, I. H., Wısnıewskı, T., & Leon, J. D. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436189.179 · Cited by 11 · see citing works
Yamakawa, A., Suganuma, M., Mitsumori, R., Niida, S., Ozaki, K., & Shigemizu, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-88526-y · Cited by 11 · see citing works
Missorting of plasma miRNAs in aging and Alzheimer's disease
Čarná, M., Novotný, J., Dragišić, N., Slavík, H., Sheardová, K., Geda, Y. E., Vyhnálek, M., Laczó, J., Hort, J., Mao, Z., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15801 · Cited by 6 · see citing works
Self-citationPalade, J., Alsop, E. B., Courtright-Lim, A., Hsieh, M., Whitsett, T. G., Galasko, D. R., & Keuren‐Jensen, K. R. V. (2024) · Cells · doi:10.3390/cells13030207 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Non-coding RNAs and Mitochondrial Dysfunction in Alzheimer’s Disease: A Systematic Review
Mocrei-Rebrean, Ș.-M., Răzniceanu, V., Pintilie, S. R., & Berindan‐Neagoe, I. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06198-9
- Authors
- Novotný, J., Čarná, M., Dammer, E., Mao, Z., & Stokin, G.
- Affiliations
- Institute of Molecular and Translational Medicine (CZ)
- Emory University (US)
- Venue
- Molecular Psychiatry
- Publisher
- openRxiv
- Published
- 2025-12-01
- Volume
- 31
- Issue
- 7
- Pages
- 3595-3604
- ISSN
- 1359-4184 (ISSN-L)
- OpenAlex
- W7128768853
- Cited by
- 1
- References
- 65
- Citations by year
- 2026: 1
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- European Union: Next Generation EU – Project National Institute for Neurological Research (LX22NPO5107 (MEYS))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, circulating microRNAs, novel miRNAs, systemic disease, pathogenesis, interleukin signaling, p38 MAPK pathway, biomarkers, miRNA target pathways
- MeSH terms
- Alzheimer Disease, Brain, Female, Humans, Male, Cohort Studies, Signal Transduction, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
